Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The present study objective is evaluate Adalimumab efficacy versus Azathioprine efficacy on
prevention of endoscopic recurrence (Rutgeerts Index= 2b, 3 or 4) in Crohn´s Disease patients
after 52 weeks of treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa